Navigation Links
GeoVax Labs, Inc. Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDA
Date:2/8/2010

ATLANTA, Feb. 8 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) (the "Company"), an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today provided an update on its vaccine trials progress.

"The HIV/AIDS population continues to grow at an alarming rate, 60,000 new infections annually, and that's just in the United States.  Preventing the spread of this disease and controlling infections through the development of vaccines remains our mission and our goal," stated Robert McNally, Ph.D., president and chief executive officer.  "On the preventative front, our Phase 2a trial is now enrolling at two locations in Peru where sites were slow to open due to local government review.  And we are making good progress with our therapeutic vaccine, as we completed a Pre-IND meeting with the U.S. FDA in December and are well into the process for submission of an IND for a Phase 1 trial.  We look forward to discussing this progress with stakeholders at the BIO CEO meeting in New York City tomorrow.

"We have engaged a full-service Clinical Research Organization (CRO) to support our therapeutic human clinical vaccine trials.  They will be providing assistance for clinical trial management; clinical, medical and safety monitoring; data management, biostatistics and medical writing services," stated Dr. McNally.

Preventative Clinical Trials – Phase 2a

The Phase 2a preventative trial has started enrolling patients at the last 2 of its 13 sites. "We are making great headway at the Iquitos and Miraflores sites in '/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
2. GeoVax Labs, Inc. Comments on Discontinuance of Mercks HIV Vaccine Trial
3. Excellent Results Received from GeoVaxs Full-Dose HIV/AIDS Vaccine Trial
4. GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update
5. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
6. GeoVax Labs, Inc. Selected by Georgia Bio as 2008 Deal of the Year Award Winner in Life Sciences Industry
7. Dr. Harriet Robinson Joins GeoVax Team as V.P. of R & D to Accelerate AIDS Vaccine Trials Program
8. GeoVax Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials
9. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2007 Financial Results
10. GeoVax Secures $10 Million Financing Commitment
11. GeoVax Reports Progress on Its AIDS Vaccine Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Ohio , Aug. 29, 2014  In ... how to leverage a hospital pharmacy as a strategic ... and national practice leader for Cardinal Health,s Innovation Delivery ... pharmacy care can benefit both hospitals and patients. ... is only one part of their job in a ...
(Date:8/29/2014)... MENLO PARK, Calif. , Aug. 29, ... (OTCQB: DMPI) ("DelMar" "the Company") today announced the filing ... Company recently changed its fiscal year end to June ... its common stock on a national securities exchange in ... as filed with the United States Securities Exchange Commission ...
(Date:8/29/2014)... , Industry professionals and ... Tweetchat taking place in real-time at CPhI Worldwide  ... UBM Live , announces the launch of ... of its kind global industry-wide Tweetchat for pharma ... aimed to stimulate conversations on key industry issues ...
Breaking Medicine Technology:Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 2Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 3
...  Genetic testing to determine a more accurate initial dosing of ... but is often done for inappropriate patients, according to a ... manager (PBM). The study will be presented on Friday, April ... Annual Meeting & Expo in San Francisco. The ...
... (NASDAQ: MASI ) announced today that it will release ... after the market closes on May 2, 2012. The conference call ... p.m. ET) and will be hosted by Joe Kiani, Chairman and ... and Chief Financial Officer. A live webcast of the ...
Cached Medicine Technology:Genetic testing for new warfarin patients is rare, but often inappropriate 2Masimo to Report First Quarter 2012 Financial Results after Market Close on May 2 2Masimo to Report First Quarter 2012 Financial Results after Market Close on May 2 3
(Date:8/31/2014)... 31, 2014 MedixSafe has become very ... and narcotics lockers . Electronic Security ... brand for distribution worldwide. “We have now shipped multiple ... McCollum, MedixSafe Sales Manager , MedixSafe is a division ... and network cabling company with over 30 years in ...
(Date:8/31/2014)... September 01, 2014 Recently, BambooIndustry.com, one of ... website with a new selection of bamboo veneers . ... 25 percent off) for these high quality products. The promotion ... company’s senior spokesman says that its top quality veneers are ... unveil the new designs of bamboo veneers. All these items ...
(Date:8/31/2014)... With years of hard work, Delta has now become one ... the company has updated its wheel loader assortment ... these items are guaranteed to be great. Additionally, they are ... is true that all items in Delta’s used cat ... The firm is making full efforts to help worldwide customers ...
(Date:8/31/2014)... (PRWEB) August 31, 2014 Asked ... the difference between "Bioavailability" and "absorption," Dr. Priya ... responded with great interest. "Bioavailability" and "absorption" ... terms in the supplement industry, second perhaps only ... Bioavailability and absorption, while related, are not ...
(Date:8/31/2014)... (PRWEB) August 31, 2014 Ticket Down ... Bolivia tickets at Dick’s Sporting Goods Park in suburban ... a plethora of games against other international teams on USA ... Cup, Mexico brought a new soccer coach aboard, Miguel Herrera, ... In the build-up before the World Cup in Brazil, the ...
Breaking Medicine News(10 mins):Health News:Memphis-based Electronic Security Specialists Now Offers MedixSafe Narcotics Cabinets Internationally 2Health News:Memphis-based Electronic Security Specialists Now Offers MedixSafe Narcotics Cabinets Internationally 3Health News:High Quality Bamboo Veneers from Bambooindustry.com Receive International Attention 2Health News:Delta Updates Its Wheel Loader Assortment With A Lot Of Cheap Used Cat 966 Loaders 2Health News:Bioavailability Vs Absorption - NutriGold Publishes Tips to Help Consumers Make Informed Decisions for Their Health 2Health News:Bioavailability Vs Absorption - NutriGold Publishes Tips to Help Consumers Make Informed Decisions for Their Health 3Health News:Bioavailability Vs Absorption - NutriGold Publishes Tips to Help Consumers Make Informed Decisions for Their Health 4Health News:Mexico vs. Bolivia Tickets at Dick’s Sporting Goods Park in Commerce City (Denver), CO: Ticket Down Slashes Ticket Prices on Mexico vs. Bolivia Exhibition Game 2Health News:Mexico vs. Bolivia Tickets at Dick’s Sporting Goods Park in Commerce City (Denver), CO: Ticket Down Slashes Ticket Prices on Mexico vs. Bolivia Exhibition Game 3
... women more likely to have infants with certain birth defects, ... Overweight and obese women are more likely to give birth ... , U.S. Centers for Disease Control and Prevention researchers analyzed ... infants without heart defects whose mothers took part in the ...
... Education in the Round presentations available through live Webcasts ... The American Dental Association,s (ADA) interactive Education in the ... Session will reach beyond the convention center to thousands ... , The ADA and the American Dental Education ...
... WASHINGTON, Oct. 1 Mental Illness Awareness Week (MIAW) is Oct. ... National Alliance on Mental Illness (NAMI) is calling attention ... the Edge: Facing Mental Illness ." , Observed annually the ... to raise public awareness of serious mental illnesses such as major ...
... Study finds vaccination rates lag behind recommended levels , THURSDAY, ... stress the need to vaccinate children against seasonal flu, as ... seasonal flu is recommended for children 6 months to 18 ... Prevention,s Committee for Immunization Practices. , A report in the ...
... , Baucus health care reform bill recognizes ... , DERBY, Conn., Oct. 1 As the ... U.S. hospitals, VA Medical Centers and health care organizations ... spotlight patient-centered approaches to health care by commemorating the ...
... Nurses Association (WSNA), representing more than 16,000 registered nurses in ... MultiCare Health System for unilaterally implementing a mandatory vaccination policy. ... vaccination or to wear face masks as a condition of ... do not comply with the policy. The lawsuit seeks an ...
Cached Medicine News:Health News:Pre-Pregnancy Weight Linked to Babies' Heart Problems 2Health News:Dental Students, Faculty Gain Live Remote Access to ADA Annual Session Courses 2Health News:Dental Students, Faculty Gain Live Remote Access to ADA Annual Session Courses 3Health News:Mental Illness Awareness Week: What You Should Know, Including PBS Broadcasts, Oct. 4-10 2Health News:Children Need Seasonal Flu Vaccine, Experts Say 2Health News:Health Care Leaders Focus on Patient-Centered Care 2Health News:Health Care Leaders Focus on Patient-Centered Care 3Health News:Washington State Nurses Association Seeks Injunction in Federal Court to Block Mandatory Vaccination Policy by MultiCare Health System 2
... assessment test approved by the U.S Food ... prognosis, adriamycin-based chemotherapy selection and Herceptin® (Trastuzumab) ... only FISH-based DNA probe HER-2 test listed ... appropriate test to aid in the selection ...
... age of 3 can choose either the PARI ... design principle applies to both:, ,Maximize aerosol ... output when the patient exhales using two one-way ... leave the nebulizer. The result is a high ...
... has been developing diverse medical ... years. Our medical-surgical products have ... innovation, quality and customer satisfaction. ... the Labtron® line of diagnostic ...
... offer a spill-proof design and effective output, ... angle. All medical nebulizers are free-standing for ... configurations are available., ,All Portex® medication ... medication nebulizers feature consistently fine misting and ...
Medicine Products: